U.S. Stocks to Watch: Nvidia, Intel, Lumentum, Coherent, Organon, and More

Dow Jones18:35

U.S. stocks were wavering Friday as investors waited for U.S. inflation data and looked ahead to weekend peace talks around the Iran conflict.

These stocks were making moves:

Nvidia was falling 0.5% in the premarket. The chip maker was on course to snap a seven-day winning streak, its longest run of consecutive daily gains since November 2023.

Intel was down 0.2% in premarket trading. The semiconductor company has been on a stellar run, its share price more than tripling in the past 12 months and hitting its highest levels for nearly five years amid excitement about chip deals with Tesla and Google.

Lumentum Holdings was gaining 5.4% in the premarket and its optical-equipment peerCoherent was rising 3.9%. The stocks were rising after Bloomberg reported that Lumentum is seeing strong AI-related demand. J.P. Morgan analysts also raised their price targets for Lumentum and Coherent, both of which arebackedby Nvidia.

Organon was gaining 11.3%. The women’s healthcare company has been boosted by a media report that India’s Sun Pharmaceutical submitted a binding offer for the company.

Simulations Plus was rising 13.7%. The company, which aims to accelerate drug development with artificial intelligence, reported an 8% rise in quarterly revenue to $24.3 million, compared with analysts’ estimates of $21.7 million.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment